AU2002308169A1 - Compositions and methods for reducing rna virus pathogenicity - Google Patents
Compositions and methods for reducing rna virus pathogenicityInfo
- Publication number
- AU2002308169A1 AU2002308169A1 AU2002308169A AU2002308169A AU2002308169A1 AU 2002308169 A1 AU2002308169 A1 AU 2002308169A1 AU 2002308169 A AU2002308169 A AU 2002308169A AU 2002308169 A AU2002308169 A AU 2002308169A AU 2002308169 A1 AU2002308169 A1 AU 2002308169A1
- Authority
- AU
- Australia
- Prior art keywords
- compositions
- methods
- rna virus
- virus pathogenicity
- reducing rna
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/04—Sulfur, selenium or tellurium; Compounds thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
- A61K39/145—Orthomyxoviridae, e.g. influenza virus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
- C12N2760/00011—Details
- C12N2760/16011—Orthomyxoviridae
- C12N2760/16111—Influenzavirus A, i.e. influenza A virus
- C12N2760/16134—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Virology (AREA)
- General Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- Microbiology (AREA)
- Mycology (AREA)
- Immunology (AREA)
- Pulmonology (AREA)
- Molecular Biology (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Inorganic Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US81938701A | 2001-03-28 | 2001-03-28 | |
US09/819,387 | 2001-03-28 | ||
PCT/EP2002/003025 WO2002078717A2 (fr) | 2001-03-28 | 2002-03-26 | Compositions et methodes pour reduire la pathogenicite de virus a arn |
Publications (1)
Publication Number | Publication Date |
---|---|
AU2002308169A1 true AU2002308169A1 (en) | 2002-10-15 |
Family
ID=25228011
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AU2002308169A Abandoned AU2002308169A1 (en) | 2001-03-28 | 2002-03-26 | Compositions and methods for reducing rna virus pathogenicity |
Country Status (2)
Country | Link |
---|---|
AU (1) | AU2002308169A1 (fr) |
WO (1) | WO2002078717A2 (fr) |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN111568921A (zh) * | 2020-04-20 | 2020-08-25 | 奥格生物技术(六安)有限公司 | 一种促进冠状病毒患者康复的新型硒制剂配方及其制备方法 |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CA2089607C (fr) * | 1992-11-05 | 1997-11-04 | Ranjit K. Chandra | Supplement nutritionnel pour personnes agees |
EP1007077B1 (fr) * | 1997-01-13 | 2009-10-07 | Emory University | Glutathione destines au traitement de l'infection grippale |
US5770217A (en) * | 1997-07-02 | 1998-06-23 | Atlatl, Inc. | Dietary supplement for hematological, immune and appetite enhancement |
-
2002
- 2002-03-26 WO PCT/EP2002/003025 patent/WO2002078717A2/fr not_active Application Discontinuation
- 2002-03-26 AU AU2002308169A patent/AU2002308169A1/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
WO2002078717A2 (fr) | 2002-10-10 |
WO2002078717A3 (fr) | 2003-08-28 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EP1292603B8 (fr) | Methodes et compositions permettant de traiter le virus de l'hepatite c | |
AU2002357119A1 (en) | Mitocidal compositions and methods | |
EP1420829A4 (fr) | Compositions immunomodulatrices, preparations, et leurs procedes d'utilisation | |
AU2001245437A1 (en) | Lightweight methods and compositions for well treating | |
AU2003254594A1 (en) | Methods and compositions for detecting sars virus and other infectious agents | |
AU2002363236A1 (en) | Compounds, pharmaceutical compositions and methods of use therefor | |
AU2001280968A1 (en) | Compositions and methods for directed gene assembly | |
AU2003239129A1 (en) | Methods and compositions for dna manipulation | |
AU2001253255A1 (en) | Compositions and methods for inhibiting gene expression | |
AU2001245987A1 (en) | Compositions and methods for gene therapy | |
AU2002346686A1 (en) | Compositions and method for treating hepatitis virus infection | |
AU2001275155A1 (en) | Superoxide-generating diazeniumdiolates, compositions comprising same, and methods for using same | |
AU2003286486A1 (en) | Methods and compositions for immunization against hiv | |
AU2002306968A1 (en) | Ogri gene disruptions, compositions and methods relating thereto | |
AU2002357748A1 (en) | Osteopontin-related compositions and methods | |
AU2003294757A1 (en) | Formulations useful against hepatitis c virus infections | |
AU2002306709A1 (en) | Oncolytic rna replicons | |
AU2002324753A1 (en) | Composition and method for treating viral infection | |
AU2002345878A1 (en) | Ilt3 and ilt4-related compositions and methods | |
AU2002353780A1 (en) | Mo54 gene disruptions, compositions and methods related thereto | |
AU2002365442A1 (en) | Method of inhibiting pathogenicity of infectious agents | |
AU2002316512A1 (en) | Compositions and methods for inhibiting human immunodeficiency virus infection by down-regulating human cellular genes | |
AU2756301A (en) | Compositions comprising genome segments and methods of using the same | |
AU2003275069A1 (en) | Compositions and methods for preventing infection | |
AU2003303948A1 (en) | Compositions and methods for preventing infection |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
MK6 | Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase |